The FDA has approved a new treatment for candidiasis called rezafungin for injection. The approval is based on a clinical trial in which George Thompson served as principal investigator.
Read MoreAn international study on Duchenne Muscular Dystrophy led by UC Davis Health will build a robust database on the progression of the disorder.
Read MoreA wide range of innovative research by medical students was on display at this year’s Poster Day, as School of Medicine continues its mission of improving health through innovative research.
Read MoreDifferences in genes involved in inflammation, immunity response and neural transmissions begin in childhood and evolve across the lifespan in brains of people with autism, a UC Davis MIND Institute has found.
Read MoreA new “whole health” weight loss initiative launching at the UC Davis Health Folsom Clinic is based on a Center for Healthcare Policy and Research study.
Read MoreChair of Physical Medicine and Rehabilitation Craig McDonald will be honored with a 2023 Top Ten Clinical Research Achievement Award, in recognition of his remarkable work on Duchenne muscular dystrophy.
Read MoreUC Davis researchers have been awarded $1.35 million from the Environmental Protection Agency to study the health impacts of wildfire smoke on pregnant people and children.
Read MoreEndocrinology researchers are investigating non-genetic influences such as diet on lipoprotein(a) levels. Their study hopes to address gaps in knowledge around lipoprotein(a) and its effects on cardiovascular disease risk.
Read MoreProfessor Aijun Wang won a $2 million grant from California’s Stem Cell Agency to develop a cure to Duchenne muscular dystrophy (DMD) using an in-utero gene editing formula.
Read MoreAsking young people to complete a survey on a tablet before visiting a mental health professional more than doubled the number of people identified at risk of psychosis.
Read MoreUC Davis Health researcher receives new funding for an interactive platform she developed that offers a real-time view of older adults living alone.
Read MoreEngaging specific serotonin receptors inside neurons promotes the growth of new connections, according to a new study. The findings will help guide efforts to discover new drugs for depression, PTSD and other disorders.
Read MoreIn 2022, the UC Davis School of Medicine scored a record amount of NIH research funding — more than $200 million in grants. This placed UC Davis among the nation’s best medical schools, ranking 32nd nationally.
Read MoreA new study finds patients who tapered their opioid use were at greater risk of emergency department visits and decreased care of chronic conditions.
Read MoreNew UC Davis Health research confirms that pediatric critical care telemedicine consults with clinicians in rural and community emergency departments result in fewer hospital transfers.
Read MoreUC Davis Health urologist Allen Gao and his team have developed a molecule, called LX-1, which could help control treatment-resistant prostate cancer.
Read MoreUC Davis School of Medicine researchers analyzed diversity strategies at dozens of graduate medical education programs nationwide. Now they’re sharing their findings about best practices.
Read MoreUC Davis Comprehensive Cancer Center researchers are part of a large-scale research study to test a new drug therapy to treat pancreatic cancer.
Read MoreIn a Q&A, UC Davis molecular exercise physiologist Keith Baar discusses the keto diet and its effect on muscle growth and brain health.
Read MoreUC Davis cancer researchers are kicking off a new study on World Cancer Day to find out why lung cancer screening rates are so low.
Read More